Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18242341 | 0.86 | TSHR (0.37) | TSHRTAAR1MAOBKCNH2PTPN2 | |
| SCHEMBL18377981 | 0.82 | TAAR1 (0.33) | TAAR1PTPN2PTPN1PTPN6PTPN11 | |
| SCHEMBL5250772 | 0.80 | TSHR (0.43) | TSHR | |
| SCHEMBL2745550 | 0.79 | GFER (0.42) | TAAR1MAOBKMT2A | |
| SCHEMBL18243026 | 0.79 | TAAR1 (0.31) | TAAR1PTPN2PTPN1PTPN6PTPN11 | |
| SCHEMBL18378241 | 0.77 | TAAR1 (0.42) | TAAR1MAOBPTPN2PTPN1PTPN6 | |
| SCHEMBL18244096 | 0.77 | TAAR1 (0.31) | TAAR1PTPN2PTPN1PTPN6PTPN11 | |
| SCHEMBL18243544 | 0.76 | TSHR (0.40) | TSHRTAAR1MAOBMEN1KMT2A | |
| SCHEMBL398644 | 0.76 | TAAR1 (0.61) | TAAR1MAOBKMT2A | |
| SCHEMBL8082952 | 0.76 | LPL (0.45) | TSHRTAAR1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | TSHR 648/4885TAAR1 1102/4885MAOB 785/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | TSHR 648/4885TAAR1 1102/4885MAOB 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.